These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22691576)

  • 1. Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis.
    Thöne J; Ellrichmann G; Faustmann PM; Gold R; Haghikia A
    Int Immunopharmacol; 2012 Sep; 14(1):9-12. PubMed ID: 22691576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis.
    Guo X; Nakamura K; Kohyama K; Harada C; Behanna HA; Watterson DM; Matsumoto Y; Harada T
    Neurosci Res; 2007 Dec; 59(4):457-66. PubMed ID: 17920148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
    Dello Russo C; Polak PE; Mercado PR; Spagnolo A; Sharp A; Murphy P; Kamal A; Burrows FJ; Fritz LC; Feinstein DL
    J Neurochem; 2006 Dec; 99(5):1351-62. PubMed ID: 17064348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IBU-octyl-cytisine, a novel bifunctional compound eliciting anti-inflammatory and cholinergic activity, ameliorates CNS inflammation by inhibition of T-cell activity.
    Nizri E; Irony-Tur-Sinai M; Lavon I; Meshulam H; Amitai G; Brenner T
    Int Immunopharmacol; 2007 Sep; 7(9):1129-39. PubMed ID: 17630191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
    Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthraquinone derivative O,O'-bis-(3'-iodopropyl)-1,4-dihydroxyanthraquinone modulates immune response and improves experimental autoimmune encephalomyelitis.
    Alves CC; Castro SB; Costa CF; Dias AT; Alves CJ; Rodrigues MF; Teixeira HC; Almeida MV; Ferreira AP
    Int Immunopharmacol; 2012 Oct; 14(2):127-32. PubMed ID: 22749732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of experimental autoimmune encephalitis by novel peptides: involvement of T regulatory cells.
    Shapira E; Brodsky B; Proscura E; Nyska A; Erlanger-Rosengarten A; Wormser U
    J Autoimmun; 2010 Aug; 35(1):98-106. PubMed ID: 20434883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Intestinal Nematode L4 Stage on Mouse Experimental Autoimmune Encephalomyelitis.
    Donskow-Łysoniewska K; Krawczak K; Bocian K; Doligalska M
    Arch Immunol Ther Exp (Warsz); 2018 Jun; 66(3):231-243. PubMed ID: 28975357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Euphol prevents experimental autoimmune encephalomyelitis in mice: evidence for the underlying mechanisms.
    Dutra RC; de Souza PR; Bento AF; Marcon R; Bicca MA; Pianowski LF; Calixto JB
    Biochem Pharmacol; 2012 Feb; 83(4):531-42. PubMed ID: 22155310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parthenolide Modulates Immune Response in Cells from C57BL/6 Mice Induced with Experimental Autoimmune Encephalomyelitis.
    de Carvalho LSA; Fontes LBA; Gazolla MC; Dias DDS; Juliano MA; Macedo GC; Otávio do Amaral Corrêa J; Da Silva Filho AA
    Planta Med; 2017 May; 83(8):693-700. PubMed ID: 27997959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB.
    Taoufik E; Tseveleki V; Chu SY; Tselios T; Karin M; Lassmann H; Szymkowski DE; Probert L
    Brain; 2011 Sep; 134(Pt 9):2722-35. PubMed ID: 21908876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glia-dependent TGF-beta signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis.
    Luo J; Ho PP; Buckwalter MS; Hsu T; Lee LY; Zhang H; Kim DK; Kim SJ; Gambhir SS; Steinman L; Wyss-Coray T
    J Clin Invest; 2007 Nov; 117(11):3306-15. PubMed ID: 17965773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.
    Samoilova EB; Horton JL; Chen Y
    Cell Immunol; 1998 Sep; 188(2):118-24. PubMed ID: 9756642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of GM-CSF and IL-4 interferes with effect of TGF-beta1 on antigen presenting cells in patients with multiple sclerosis and in rats with experimental autoimmune encephalomyelitis.
    Xiao BG; Zhu WH; Lu CZ
    Cell Immunol; 2007 Sep; 249(1):30-6. PubMed ID: 18061154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of experimental autoimmune encephalomyelitis by ghrelin.
    Theil MM; Miyake S; Mizuno M; Tomi C; Croxford JL; Hosoda H; Theil J; von Hörsten S; Yokote H; Chiba A; Lin Y; Oki S; Akamizu T; Kangawa K; Yamamura T
    J Immunol; 2009 Aug; 183(4):2859-66. PubMed ID: 19620309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.
    Feinstein DL; Galea E; Gavrilyuk V; Brosnan CF; Whitacre CC; Dumitrescu-Ozimek L; Landreth GE; Pershadsingh HA; Weinberg G; Heneka MT
    Ann Neurol; 2002 Jun; 51(6):694-702. PubMed ID: 12112074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment.
    Castro SB; Junior CO; Alves CC; Dias AT; Alves LL; Mazzoccoli L; Mesquita FP; Figueiredo NS; Juliano MA; Castañon MC; Gameiro J; Almeida MV; Teixeira HC; Ferreira AP
    Int Immunopharmacol; 2012 Feb; 12(2):465-70. PubMed ID: 22245971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis.
    De Paula ML; Rodrigues DH; Teixeira HC; Barsante MM; Souza MA; Ferreira AP
    Int Immunopharmacol; 2008 Sep; 8(9):1291-7. PubMed ID: 18602076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.